SBIR-STTR Award

Foley Urological Catheter Insertion Tool And Method
Award last edited on: 2/1/12

Sponsored Program
SBIR
Awarding Agency
NIH : NIDDK
Total Award Amount
$150,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Thomas W Winegar

Company Information

Urovalve Inc

211 Warren Street Suite 518
Newark, NJ 07103
   (973) 596-1350
   harveydhoman@urovalve.com
   www.urovalve.com
Location: Single
Congr. District: 10
County: Essex

Phase I

Contract Number: 1R43DK091093-01A1
Start Date: 9/1/11    Completed: 8/31/12
Phase I year
2011
Phase I Amount
$150,000
Urovalve, Inc. is developing a novel, patent pending insertion device preassembled to a Foley catheter. The Surinate(R) Foley Catheter with Inserter System is designed to enable skilled healthcare professionals such as urologists and experienced urological nurses to insert smaller, softer, more comfortable Foley catheters, especially in those instances in which traditional insertion is difficult. This is expected to dramatically reduce healthcare costs while improving patient comfort and health. Healthcare costs will be reduced because the Surinate(R) Foley Catheter with Inserter System is more economical than more complex approaches such as the Heyman Filiform/Follower Slipover System. The procedure is also likely to be much faster than, for instance, urethral dilation or cystoscopy. Patient comfort is expected to be greatly enhanced. Unlike dilation, the envisioned device is expected to place the catheter on a single insertion, yielding a technique that significantly reduces the amount of manipulation of the urethra that is required. In addition, the healthcare provider will be able to choose a smaller, more comfortable catheter for his or her patient to wear as opposed to choosing a larger catheter simply to have enough column strength for the insertion procedure. During insertion with the device, an integral pusher tube adds column strength to the catheter while retaining the flexibility necessary to navigate the turns of the urethra. A proprietary lock mechanism near the tip of the catheter ensures that the pusher tube can not dislodge during the procedure. The pusher tube remains encased in the catheter throughout the insertion process. After insertion, the proximal lock is disengaged and the pusher tube is removed. This unique configuration allows the catheter to be both stiff, which is useful for navigating certain anatomic variants such as enlarged prostates, and small, which is useful for different obstructions such as strictures. The specific aims for phase 1 of this project are: 1. Manufacturing and Packaging a. Creation of the first batches of devices 2. Testing and Sterilization a. Biocompatibility, shelf life, sterility, and in vitro tests vs. recognized standards as well as specific design input criteria 3. Validation a. Pilot clinical trial to assess initial safety and effectiveness

Public Health Relevance:
The relevance to public health of the proposed project lies in its ability to cost effectively facilitate insertion of a Foley catheter in the presence of obstructions. The Surinate(R) Foley Catheter with Inserter System is expected to improve patient health and comfort by eliminating extra manipulations of the urethra while placing a smaller, more flexible catheter in a single pass. Healthcare costs are expected to decrease due to the system's economical design, reduced care time, and minimized complications.

Thesaurus Terms:
Anatomic;Anatomical Sciences;Anatomy;Caring;Cathetergram;Catheterization;Catheters;Clinical Trials;Complex;Cystoscopy;Devices;Dilator;Drainage;Drainage Procedure;Effectiveness;Ensure;Health;Health Care Costs;Health Care Professional;Health Care Providers;Health Costs;Health Personnel;Health Professional;Healthcare Costs;Healthcare Providers;Healthcare Professional;Healthcare Worker;Industry;Loinc Axis 4 System;Legal Patent;Life;Maintenance;Methods;Nurses;Obstruction;Patents;Patients;Phase;Procedures;Process;Prostate;Prostate Gland;Prostatic Gland;Public Health;Safety;Sterility;Sterilization;System;Techniques;Tensile Strength;Testing;Time;Traction;Tube;Urethra;Urologist;Validation;Variant;Variation;Biocompatibility;Biomaterial Compatibility;Clinical Investigation;Cost;Cost Effective;Cost-Effective;Design;Designing;Experience;Flexibility;Flexible;Health Care Personnel;Health Care Worker;Health Provider;Healthcare Personnel;Improved;In Vitro Testing;Medical Personnel;Novel;Public Health Medicine (Field);Response;Sterile;Tool;Treatment Provider;Urethral;Urologic;Urological

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----